Covid-19 roundup: Cancer biotech to submit EUA for Covid drug; FDA OKs Eli Lilly JAK inhibitor

As vaccine talk wanes, re-purposed treatments take center stage for Covid-19.

Veru, which started out as a cancer outfit, plans to request an EUA for its drug sabizabulin as a Covid-19 treatment for patients at high risk for acute respiratory distress syndrome (ARDS), it announced today.

Last month, Veru said...

Click to view original post